Sickle cell disease in Ontario, Canada: an epidemiologic profile based on health administrative data
暂无分享,去创建一个
[1] Vijay Kumar Chattu,et al. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021 , 2023, The Lancet. Haematology.
[2] J. Parboosingh,et al. The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular Testing , 2021, International journal of neonatal screening.
[3] M. Castonguay,et al. COVID-19 and Sickle Cell Disease in the Province of Quebec: Morbidity and Mortality Rates Derived from the Provincial Registry , 2021, Blood.
[4] S. Grosse,et al. Administrative data identify sickle cell disease: A critical review of approaches in U.S. health services research , 2020, Pediatric blood & cancer.
[5] M. DeBaun,et al. Low educational level of head of household, as a proxy for poverty, is associated with severe anaemia among children with sickle cell disease living in a low‐resource setting: evidence from the SPRING trial , 2020, British journal of haematology.
[6] E. Akl,et al. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. , 2020, Blood advances.
[7] A. Kulozik,et al. Sickle cell disease in Germany: Results from a national registry , 2019, Pediatric blood & cancer.
[8] P. Chakraborty,et al. Increasing Incidence and Prevalence of Pathologic Hemoglobinopathies Among Children in Ontario, Canada from 1991-2013 , 2018, Blood.
[9] Á. Cervera,et al. National registry of hemoglobinopathies in Spain (REPHem) , 2017, Pediatric blood & cancer.
[10] M. Hulihan,et al. Emergency department utilization by Californians with sickle cell disease, 2005–2014 , 2017, Pediatric blood & cancer.
[11] K. Wailoo. Sickle Cell Disease - A History of Progress and Peril. , 2017, The New England journal of medicine.
[12] A. Qureshi,et al. Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion , 2017, British journal of haematology.
[13] C. Steiner,et al. Trends in Hospitalizations With a Red Blood Cell Transfusion, 2000–2013 , 2016 .
[14] A. Douiri,et al. Survival in adults with sickle cell disease in a high-income setting. , 2016, Blood.
[15] V. Gordeuk,et al. Blood transfusion and 30‐day readmission rate in adult patients hospitalized with sickle cell disease crisis , 2015, Transfusion.
[16] Xueqing Yu,et al. Sex difference of autosomal alleles in populations of European and African descent , 2015, Genes & Genomics.
[17] Evidence-Based Management of Sickle Cell Disease: Expert Panel Report, 2014 , 2014, Pediatrics.
[18] A. Tatem,et al. Global migration and the changing distribution of sickle haemoglobin: a quantitative study of temporal trends between 1960 and 2000 , 2014, The Lancet. Global health.
[19] J. Gurney,et al. Hydroxyurea Use and Hospitalization Trends in a Comprehensive Pediatric Sickle Cell Program , 2013, PloS one.
[20] M. Gladwin,et al. Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. , 2011, JAMA.
[21] Pamela L Owens,et al. Acute care utilization and rehospitalizations for sickle cell disease. , 2010, JAMA.
[22] P. Kavanagh,et al. Sickle cell disease-related pediatric medical expenditures in the U.S. , 2010, American journal of preventive medicine.
[23] K. Hassell. Population estimates of sickle cell disease in the U.S. , 2010, American journal of preventive medicine.
[24] S. Ballas. The cost of health care for patients with sickle cell disease , 2009, American journal of hematology.
[25] A. Hartzema,et al. The cost of health care for children and adults with sickle cell disease , 2009, American journal of hematology.
[26] A. Giardino,et al. Healthcare utilization and expenditures for low income children with sickle cell disease , 2009, Pediatric blood & cancer.
[27] Cage S. Johnson,et al. Outcome of Sickle Cell Anemia: A 4-Decade Observational Study of 1056 Patients , 2005, Medicine.
[28] P. Lane. Sickle cell disease. , 1996, Pediatric clinics of North America.
[29] O. Platt,et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. , 1994, The New England journal of medicine.
[30] E Vichinsky,et al. Pain in sickle cell disease. Rates and risk factors. , 1991, The New England journal of medicine.
[31] P. Sperryn,et al. Blood. , 1989, British journal of sports medicine.
[32] K. Baum,et al. The Painful Crisis of Homozygous Sickle Cell Disease: A Study of Risk Factors , 1987 .
[33] Michel Tousignant,et al. Children’s understanding of the relationship between addition and subtraction , 2008, Cognition.